News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
A2A Pharmaceuticals, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/02/2023 |
4
| A2A Pharmaceuticals, Inc. (10% Owner) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Sold 75,000 shares
@ $33.81, valued at
$2.5M
Sold 50,000 shares
@ $34.5633, valued at
$1.7M
|
|
| 05/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/17/2023 |
4
| A2A Pharmaceuticals, Inc. (10% Owner) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Sold 25,000 shares
@ $33.84, valued at
$846k
|
|
| 05/10/2023 |
4
| A2A Pharmaceuticals, Inc. (10% Owner) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Sold 100,000 shares
@ $33.9931, valued at
$3.4M
Sold 150,000 shares
@ $34.5048, valued at
$5.2M
|
|
| 04/27/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/19/2022 |
4
| A2A Pharmaceuticals, Inc. (10% Owner) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Bought 30,684 shares
@ $13.872, valued at
$425.6k
|
|
| 07/25/2022 |
4
| A2A Pharmaceuticals, Inc. (10% Owner) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Sold 34,658 shares
@ $11.21, valued at
$388.5k
|
|
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|